AT

Anthony Tennyson

Person

Heard in 2 episodes across 1 show since Aug 2026

Anthony Tennyson is the Chief Executive Officer of Solvonis Therapeutics plc, a CNS-focused company listed on the London Stock Exchange under the ticker SVNS. He is known for leading the company as it develops its therapeutics business.

Episodes

2
across 1 show

First heard

Aug 2026

Guest appearances

2

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20260
Oct 20261

What Anthony Tennyson has said on podcasts

11 statements

  1. on SVN001PositiveAug 26, 2026· The Sunday Roast

    EU trial data could improve SVN001’s probability of EU marketing approval.

    “what our hope would be that if we have EU data in the trial, it would increase the probability of an accepted marketing authorization or marketing approval in certain EU countries in due course.”

    Listen at 3:59

    Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS
  2. on SVN002PositiveAug 26, 2026· The Sunday Roast

    Funding enables SVN002 bridge completion and FDA engagement for Phase 2B support.

    “what this money enables us to do is to complete that process and then engage with the FDA, present the data to them and hopefully gain their support for a phase two program, but ideally a phase two B program.”

    Listen at 4:57

    Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS
  3. on SVN015PositiveAug 26, 2026· The Sunday Roast

    Successful SVN015 work could position Solvonis to seek NIDA clinical-development funding.

    “if that's successful, then what we would hope is we'd be able to be well positioned to apply for grant funding from NIDA to bring that program forward into clinic and into humans.”

    Listen at 5:47

    Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

2 episodes featuring Anthony Tennyson, newest first

Anthony Tennyson · PodLume